Vallance HD, Koochin A, Branov J, Rosen-Heath A, Bosdet T, Wang Z, Hazen SL, Horvath G
Without clear guardrails, the promise of empowerment risks devolving into a subscription model of self-monitoring, where the metric of success is not patient health, but user retention
Ocular manifestations and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparison with adult patients
GLP-1 Cardiovascular Meta-Analysis Nature 2022 View on PubMed GLP-1/GIP Dual Agonism in NASH: Liver Fat Reduction and Fibrosis Improvement Finding: Phase 2b trial of a GLP-1/GIP dual agonist in 190 patients with NASH (non-alcoholic steatohepatitis)
In: Peri-operative anesthetic management in liver transplantation